MPR1d
Tremfya Approved for Moderately to Severely Active Crohn Disease
The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).
MPR1d
FDA Approves Gvoke VialDx to Inhibit GI Motility During Diagnostic Procedures
Gvoke VialDx is a concentrated liquid glucagon product. For diagnostic procedures, it works as a gastrointestinal motility inhibitor. The product is supplied as a single-dose vial containing 1mg of ...
awm.gov.au2d
The psychology of air power / A. P. N. Lambert.
Author Royal United Services Institute for Defence and Security Studies.; Lambert, A. P. N.; ...
awm.gov.au4d
The framework of a science of infantry tactics / by B.H. Liddell Hart; with a foreword by Sir Ivor Maxse.
Author Liddell Hart, B. H. (Basil Henry), Sir, 1895-1970.; Royal Engineers' Institute (Great Britain); Royal United Service Institution (Great Britain); ...